<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-pharmaceuticals-13-00096">
 <label>31.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Booth</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Matukas</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Tomlinson</surname>
    <given-names>G.A.</given-names>
   </name>
   <name>
    <surname>Rachlis</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Rose</surname>
    <given-names>D.B.</given-names>
   </name>
   <name>
    <surname>Dwosh</surname>
    <given-names>H.A.</given-names>
   </name>
   <name>
    <surname>Walmsley</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Mazzulli</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Avendano</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Derkach</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area</article-title>
  <source>JAMA</source>
  <year>2003</year>
  <volume>289</volume>
  <fpage>2801</fpage>
  <lpage>2809</lpage>
  <pub-id pub-id-type="doi">10.1001/jama.289.21.JOC30885</pub-id>
  <pub-id pub-id-type="pmid">12734147</pub-id>
 </element-citation>
</ref>
